Clinical Decisions Without EEG: High Anti-Seizure Medication Use Before EEG in Infants and Its Implications
Abstract
Neonatal seizures are challenging to diagnose due to subtle clinical presentations and require video-EEG for confirmatory diagnosis. However, video-EEG is not always available, so clinicians must sometimes decide to treat neonatal seizures prior to diagnostic confirmation. The extent of this gap in clinical care is not previously described. This retrospective study examined anti-seizure medication (ASM) use in 115 infants who underwent video-EEG at Mount Sinai. Of 46 infants treated with ASMs, 59% received loading doses before EEG. Among these, 89% showed epileptiform activity and 52% (14/27) had seizures on EEG. Mortality among treated infants was high (30%). These findings highlight the significant reliance on clinical judgment without EEG when treating neonatal seizures. Our data support future work to develop scalable, accessible tools to improve timely and accurate treatment of neonatal seizures.
Related articles
Related articles are currently not available for this article.